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THE need for controlling the influence ofsolvents used as vehicles for carcino-
genic hydrocarbons was recognized by Burrows, Hieger and Kennaway (1932),
who reported experiments designed to test the fat solvents then in use for this
pui-pose, for possible carcinogenic action on the connective tissues of rats and
mice. Subsequent work showed that in fact lard, which had been previously
heated to 140' C., was a potential carcinogen for the connective tissues of fowls
(Peacock, 1933), and that lard alone could give rise to spindle-cell tumours in
rats (Barry and Cook, 1934) ; and later that lard, olive oil'and other fatty
materials could induce connective-tissue tumours, some of which appeared to be
malignant in rats, but not in mice, in the experience of Burrows, Hieger and
Kennaway (1936).
The first instance of undoubted sarconia induction at the site of the injection
of lard in fowls cited above was complicated by the fact that the same birds had
been injected with a solution of 1:2:5:6-dibenzanthracene in lard in the right
breast and with lard alone in the left breast. Tumours developed in the right
breast only in 7 of these birds, and in both breasts in 3 others. The lard had
been heated to 140' C. during the preparation of the material, and cooled to 40'
before injectioii. The following comment is quoted from the above reference :
" The possibility that heated lard alone may have determined the occurrence. of
tumours in a susceptible bird cannot be excluded. . . . Incidentally these
experiments suggest that the quantity of dibenzanthracene actually required to
initiate sarcomatous growth must be remarkably small, since the bulk of the
the injection appears to remain encapsulated throughout the expei-inient
"
(Peacock, 1933). The latter assumption subsequently proved to be wrong.
To test this point, Chalmers (1934) analysed the contents of encapsulated
niatter from the site of dibenzanthracene lard injection in one of Peacock's
sarcoiiia-bearing fowls, which died 7 months after the lastinjectioii. The method
of spectrographic analysis en-iployed was capable ofdetectiiig 0-01 mg. of diben-
zaiitlii-acene in an exti-act of fowl inuscle, but failed to detect dibenzaiithracene
in the extract ofencapsulated debris from this bird.
Furtlier tests oii birds in the same experiment confiriiied the abseiice of
demonstrable dibenzanthracene 6 months or more after injection. In order to
avoid the use offoreign fats, chicken fat and egg yolk fat were used as vehicles
for the injection of dibenzanthracene into fowls. It was found that when either
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of these solvents was used as vehicle dibenzanthracene rapidly disappeared from
the site ofinjection, and was undetectable after 3 weeks. InparaRelexperiments
(Peacock, 1935, 1936a) similarly mijected birds were kept for longer periods, to
test the influence of the solvent on the carcinogenic response. No tumours
occurred in 12 birds injected with chicken-fat containing 1-2 mg. dibenzan-
thracene in 0-4 per cent solution. Moreover, in this group no tissue reaction
could be found at the site of injection after a few months, indicating that the
homologous fat had caused httle disturbance. However, with egg yolk fat
as vehicle for dibenzanthmmne m 0-4 per cent solution, 2 metastasising sarcomas
occurred among 4 birds that s'urvived 9 months or more after injection. Birds
inject-ed with yolk- fat showed fibrous cysts at the site of injection, sinular t-0
those observed in the lard experiment, and in contrast with the absence of such
local reaction in birds injected with chicken-fat. There seemed, therefore, to
be some aetiological connection bet-w-een the
" foreignness
" of the solvent used
as vehicle and the local tissue reaction and the ultimate carcinogenic response
t-o dibenzantli-racene.
Owing to the costlv and time-consuming nature oflong-term experinients on
fowls work was begun on similar lines on mice. While these experiments were
in progress Berenblum (1938) reported the co-carcinogenic action of croton oil.
He had previouslv shown (1929) that mustard gas in dilute solution and (1935)
cantharidin had anticarcinogenic properties for the skin of mice, and in the
interim had found that no simple relationship between irritant and co- or anti-
carcinogenic action was demonstrable. More recentl.y Friedwald and Rous
(I944a, b) reported that chloroform andturpentine both promote the carcinogenic
actionofmethvlcholanthrene, andMottram (I944a, b) demonstratedthatrepeated
painting with croton oil or resin could elicit a carcinogenic response in mice
painted only once with 3:4-benzpyrene.
Thusitis nowob-6ousthat solvents mavhave co- oranti-carcinogenicinfluence
in addition to their capacity as solvents to retain chemical carcinogens at the
site ofinjection for variable periods.
On the basis of the lack of reaction in fowls to injections of chicken fat, we
used mouse-fat as a solvent for benzpyrene injected into mice, with the idea of
exciting a minimal disturbance due t-o the solvent. In this specie-S also we
observed verv little tissue reaction to homologous fat. It seemed fik-elv, there-
fore, that benzpy-rene dissolved in mouse-fat would be readily absorbed along
with the fat from the site, ofinjection, and thisproved to be the case. In a series
of experiments in which various solvents were used as vehicles for benzpymne
it was found that those solvents which remained encapsulated at the site of in-
jection, e.g. olive oil, tended to retain the dissolved benzp-%-rene as judged by the
persistence of violet fluorescence, where-as in the case of those that were rapidlv
absorbed, e.g. mouse fat or ether, fluorescence could not, be detected after a few
weeks (Peacock and Beck, 1938). Moreover, in the fornier group the incidence
of sarcomas was high, and in the latter group it was low. This suggested that
there mav be an optimal period for the retention of a carcinogen at the site of
injection for the induction of a tumour, and that in mice this period was about
a months.
Dickens and Weil-Malherbe (1942) at first confirmed our observation with
mouse fat', but later (1946a), as a result ofintensive experiments, found that the
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solvent. Fats with a high phospho-lipid content seemed to inhibit carcinogenic
action, while those with a high cholesterol content seemed to enhance it. To
obviate variations between samples of fat of animal or vegetable origin, Dickens
and Weil-Malherbe adopted tricaprylin as a solvent for benzpyrene in further
experiments. They also reported the interesting fact that certain purine com-
pounds are good solvents for hydrocarbons giving aqueous solutions (Weil-
Malherbe, 1946a).
It had already been shown by Andervont and Lorenz (1937) that serum was
a solvent for benzpyrene and other hydrocarbons.
The solventcapacity ofthecirculating blood must thus be a factor in determin-
ing the localizationin, or elimination ofhydrocarbonsfrom, the site of their injec-
tion; but there'is, as Dickenspointed out (1947), a distinction to be made between
elimination of unchanged hydrocarbon and local metabolism, processes which
might elicit very different local tissue reactioris, though either would reduce the
amount of detectable hydrocarbon at the site of injection.
It still remained to be shown whether or not the fluorescence at the site of
injection of benzpyrene (Peacock and Beck, 1938) throughout the latent period
of careinogenesis was due to the unchanged hydrocarbon. In the experiment
now reported tricaprylin was used as vehicle for the injection of benzpyrene, as
advocated by Dickens and Weil-Malherbe.
EXPERIMENTAL.
Thirty-six mice of mixed stock were each injected subcutaneously in the right
flank with 0-3 ml. of a 0- I per cent solution of benzpyrene in tricaprylin ; 3:4-
benzpyrene was supplied by Ward, Blenkinsop & Co., Ltd., London, and tri-
caprylin by British Drug Houses, Ltd. The mice were killed after different
periods (Table 1), the subcutaneous tissues exposed and examined for ultra-violet
fluorescence. Sixteen of 20 mice killed at various times over aperiod of 7 months
had fluorescent material located at the original site ofinjection ; ulceration and
sepsis at the site ofinjection killed 4 mice early in the experiment. In 3 of these
mice no sign of the injected material was found, probably due to sloughing and
leakage from the site of injection. The fourth had a small spot of fluorescence.
These mice were not examined further ; in the remainder the fluorescent material
was extracted with benzene, with the exception of 2 mice, which died after 412
-and 51 months, both showing persistent fluorescence and tumours at the site of
injection.
After the third month of experiinent tumours began to be clinically recog-
nized at the sites of injection. As most of these tumours were similar to many
such induced sarcomas in mice, not a11 were histologically examined. One
tumour in the abdominal cavity associated with intraperitoneal deposits of
fluorescent material was probably induced by benzpyrene injected accidentally
through the abdominal w,-,11. This tumour was apleomorphic sarcoma. Another
tumour occurred in an ulcerated area at the site ofinjection. This proved to be
a squamous carcinoma. Of the remaining tumours the only one examined histo-
logicallv was the fai-iiiliai- type ofspindle-cell sarcoma.
As iar as the injected benzpyrene was concerned the gross appearances in
normal and ultraviolet light varied considerably in different mice, and the pre-
liminary method of extraction was modified to suit the local condition. In most
cases one or niore sinall fluorescent cysts were present, and these were openedandSOLVENTS AND R'ESPONSE TO CARCINOGENM HYDROCARBONS 11)99
their contents expressed into 2 ml. benzene, -.iel a fluorescent solution. In
other mice numerous minute spots of brightly fluorescent material pervading a
tumour or merely a general fluorescence locaUmed in the neighbourhood of the
site ofinjection were found. Theregion oftissuebearing the fluoresmnt mat-erial
wa-s dissected out in order to the extraction of normal or adventitious
fluorescent material which might mask the fluoresmnee of small traces of the
carcinogen. In these cases the fluorescent tissues were triturated in benzene
with a glass rod, or if this was unsuccessful the tissue was hydrolysed with 10
per cent aqueous alcohofic potash (50 ml. EtOH to 50 ml. H20), the alcohol
removed, the iin ;aponifiable fi-action extractedwith 5 ml.benzene,andthebenzene
extract dried over anhydrous sodium sulphate.
Since the main object of these experiments was to demonstrate the pre-sence
or absence of benz vne after various periods, the experiments were not con-
ducted quantitatively. However, the limit of sensitivity of the method of
detection provides some indication of the quantities involved (vi& infra). To
eliminate the possibihty of a false positive resWt due to traces of benzpvrene
adhering to the apparatus used in the experiments, benzene washings of each
piece of chemical apparatus or other instrument used, were examined under the
ultraviolet lamp imniediately before its use. Attention was drawn to the neces-
sity for such precautions ri_-,cently (Anderson, 1947a). Owing t-o the difficulty of
eliminating minute traces ofmaterialfromapparatus, such traces may be recorded
by the fluorescence method ofdetection, and lead to a false positi've result. The
benzene (British Drug Houses, Ltd., AR.) used was rectified before use and was
fi-ee from visible fluorescence. It is considered that the' precautions employed
exclude the possibility of any faLse positive result.
The fluoresmnee spectra were recorded with aHilger Medium Quartz Spectro-
graph, using Ilford Iso-Zenith Plates. A smaR gLus cell of 0-5 ml. capacity
held the solution for test close to the slit ofthespectrograph, andthe fluorescence
was excited by radiation from a G.E.C. Osira-lamp focused on t-o the cell by a
condensing lens. The slit width usedthroughout was 0-I mni. and trhe exposures
varied from 1-60 minutes,depending on the fluorescenceintensity ofthe solution.
RESULTS.
T& n-ature of the fluore-went m-aterial at the site of inj'eclion.
Therelativeintensitiesofthecharacteristic bands ofthefluorescencespectrum of
benzpy-reneinpurebenzene(Fig. 1, Spectrum (a)) aredependent on thesensitivity ofthephotographic emulsion to the different wavelengths. With the apparatus
usedin theseexperiments it ispossible to obtain agoodispectrum ofbenzpy-rene at
a concentration of 0-001 per cent with an exposure of 5 minutes, while if a 60
minut-es' exposure is used it is just possible to detect the two strong groups of
bands at 4030-4120A and 4260-4400A at a concentration of I tLg./100 ml.
This represents the practical limit ofthe technique, for it isjustpossible todetect
fluorescence in a solution ofthis concentration bv visualinspection. The volume
of solution used in the test is 0-5 ml., representing 0-005 tLg. benzpyrene at the
limiting concentration.
Detection of benzpvrene in tissues examined by the technique described
above implies that at least 0-02 [Lg. benzpyrene was present. In fact, however,
the quantities of benzpyrene present at the sites ofinjection must have greatly300 P. R. PEACOCK, S. BECK AND W. ANDERSON
exceeded this value for several reasons : (1) No attempt was made to extract
all the fluorescent material present at the site of injection. (2) The exposures
requii-ed to demonstrate benzpyrene were under 60 minutes in every case. (3)
Fl(,,-,. I.-Fluorescence spectra of 3:4-benzpyrene and metabolites.
In all tllese cases the benzpyrene baiids were very iiiuch stronger than those
obtained with a solution of coiicentration I tig.1100 ml. benzpyrene (limit of
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Inlong exposures reflection ofmercury lines is recordedalono,, with the fluores-
cence spectrum of the extract under examination. This is not a disadvantage,
as it is possible to disting-uish between the sharp lines of the mercurv spectruni
and the characteristic groups of bands- due to the fluorescence of benzpyreiie.
The mercurv fines accurately check the wave-leno,,th scale.
Spectrum (b) shows the weak mercurv, iine at 4040 A and 4071) A in approxi-
matelv the same region as the strong fluorescent bands of benzpyrene at, 40
4120 The strong mercurv line 3650 A stands out clearIv in the near-ultra-
violet region ; the latter line can be seen in all fluorescent spectra taken with
this equipment, but the weaker mercurv lines in the visible spectrum are onlv
obv-ious after long exposures.
Spectrum (c) e-xposure 20 minutes shows the fluorescence of a metabolite of
benzpvrene extracted from the faeces of rats fed with benzpyrene clissolved in
milk, and corresponds t-o the fluorescent derivative of benzpyrene detected bv
Peacock (I936b) in the bile of rabbits, guinea-pigs and fowls after intravenotis
injection of benzpyrene colloid. It was later deduced that this derivative was
a monohvdroxy benzpyrene (Chalmers and CroNdoot, 1941), and further work
indicated that it was W-hydroxy-benzpyrene (Berenblum. Crowfoot, Holiday and
Schoental, 1943). Weigert and Mottram (I946) have pointed out that the for-
mation of a monohvdroxv benzpyrene mav be preceded bv the production of a
diol, and have pubfished fluorescence spectrograms of fractions extracted from
tissues e-xposed to benzpyrene in which the main fluorescence is in the region
4200-4600 A. Weigert, Calcutt and Powell (I947) showed that in mouse skin
painted with benzpyrene the onlv detectable metabolite over periods up to 24
hours is that corresponding toWeigert, and'Mottram's BPX.,represented bv tlielii




whereR, andR2 are unidentified cell constituents.
The different fluorescence spectra encountered in the present investiffation
are now considered in relation to the length of time after injection.
(1) Extracts made 4 manthsafteri-njectiwi.-Fluoreseent material was extracted
from 10 mice. A suit-able spectrum was obtained from all ofthese. with exposures
of 5-10 minutes-a representative spectrum is reproduced as Spectrum (d). All
the spectra were the same, and are identical with that ofbenzpyrene (Spectruni
(a)).
(2) Extract.3 5 months after injeclion.-Fluoreseent material was extracted
from 2 mice. Spectra (e) and (f) correspond to these extracts. Both spectra
have the benzpyrene bands at 403-0-4120 A. but the fluorescence also extends
over the region 4260-4WO A. which coincides with the longer wave-length
region of the benzpyrene spectrum and also with the range of the benzpyrene
metabofites. Theinterestingfeature ofthesespectra is that thev show an increase
in the intensitv of the fluorescence in the latter region, compared with the
spectrum ofunchanged benzpvrene. These spectra are interpreted as a mixture
of the spectra of benzpy-rene and another material witli a spectrum similar to
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(3) Extracts 6 months after injection.-Fluorescent material was extracted
from 2 mice. The first of these had a tumour in which was embedded a small
blue fluorescent cyst. Spectrum (g) was derived from material extracted from
this cyst (20 iiiiniites' exposure). It is similar to those of extracts from the mice
kille(I at 5 nionths. The other mouse had 2 cysts with pink fluorescent pus and
a siiiall bluis'li fluorescent cyst. The corresponding spectrum (i) (60 minutes'
expostire) sliows none of the bands of benzpyrene. It is considered probable
that the niaterial from this cyst at the site of injection is a metabolite of benz-
pyrene. The spectruni consists of a band frot-n 4300-4500 A. There was not
sitfficient niaterial for a detailed study of the chemical properties of the
extract, biit it was foiin(I that the fitioreseence was unaffected by alkali. The
available evidence strongly suggests that this material is similar to the known
iiietabolites ofbenzpyrene. Spectrum (h) is that ofbenzpyreiie. It will be seen
that the super-positioii of' Spectra (h) and (i) would give a spectriiiil siiililar to
(e), (f) or (ti), and it is suggested that these spectra are to be explaine(I in tllis
w,ay as mixtiires ofbeiizpyrene and one or more ofits metabolites.
(4) Extracts 7 month-s after injection.-Fluorescent niaterial was extracted
froi-n 2 mice, both bearing tumours, one large and one small. The extract frojii
the mouse with the large tumour gave a spectrum similar to that shown in
Spectrum (i) after 60 minutes' exposure. There was no evidence of the presence
of benzpyrene. The fluorescence spectruni of'the extract from the mouse witli
the sniall tumour showed neither benzpyrene nor a known metabolite, but gave
inerely a continuous spectrum.
Table I shows the relationship which exists between the tumour incidence
aiid the persistence ofbenzpyrene at the site ofinjection. It may be noted that
the W iiiiee which sur-\.-ived lonaest lia(l no titinotirs an(I iio persistent fltioresceiiee,
,tt, the site ofii-jectioii.
TABLE 1.
Dtiration of Nuinber of Ttimoiir Fluorescence,
experimeiit. of site of Spectrographic examination.
(day8.) inice killed. inei(telic(l. injectioii.
123 12 -3/12 10/12 BenzpyreneidentifiedinthelO
fliioreseent extracts, includ-
ing tumour mice.
153 3 1 2/3 Benzpyrene in 2 fluorescent
extracts, including tumour
mouse ; additionalband sug-
gests metabolite in both.
198 2 1/2 1/2 Benzpyrene in tumour mouse.
? Metabolite in other mouse.
232 3 2/3 1/3 ? Metabolite in tumour mouse
with large tumour. General
fluorescence only in other
tumour mouse.
307 10 0/10 0/10
NOT-H.-I n-ioiise died after 136 days with a tiimour and persistent fluorescenee at the site of
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DISCU,SS10N-.
It is clear from the above results that with tricaprvlin as solvent, benzpyrene,
persisted at the site of injection up to 6 iiioiitlis. at least in those mice wliieli
developed tuniours. DurhW the latent period a iiietabo'lite or metabolites also
niade their appearance at or near the site of injeetion. The absenee of benz-
pyrene from extracts of two tumour-bearing mice killed -4 months after a siiigle
injection of benzpyrene does not preclude the possibilitv that the uneliaiiored
hvdrocarbon was still present at the inception of the tuiiiour process as it was in
tfie other tumour-bearing animals killed after shorter periodss.
Thus the results ofthisexperiment accord well .,A-ith otir previous observations-
(Peacock and Beck, 1938) that when fluorescence remained at the site ofinjectioii
in iiiiee for 5 months or more there was a hiah incidence of sarcoma. wherea..;
when no detectable fluorescence was present after 3 montlis. the sarcoiiia iiiei-
dence was low. Furthermore. Weil-Malherbe (194W)) used a 5 per cent aqueou:s
solution of tetramettivIuric acid as a -.solvent for benzpyrene. and injected o-3
Jill., equivalent to 0-:.. mor. benzpy-rene, in mice. He iound'that under these
conditions fluorescence was absent from the site of injeetion after -2. weeks, and
onl,v one out of 24) mice developed a tumour. One of us (S. B.) observed that
an aqueous soap solution of benzpyrene is also quicklv absorbed from the site
of injection in mice, and no tumours have been foui;d amongst 22 mice that
sur-Oved for 6 months after injection, equivalent to 0-1 mu. of benzpyrene.
The method of examination of mice used bv Dickens and Weil-Malherbe
differed from ours. Thev extracted the whole animals and estimated the rate
of elimination of benzpvrene in terms of the unchancred hvdrocarbons in their
extract. On this basis Dickens (1947) states that
" the surprising result was
obtained that the more rapid elimination of benzpyrene was associated witli
the higher carcinogenic activity, and slower elimination mith lower acti-6ty."
The terms rapid or
" slow
" ehmination require further definition. In
fact the graphs published bv Dickens and Weil-'-Nlalherbe (1946b) show. in the
case of tricaprylin alone, and of tricaprylin plus phospholipids as solvents for
benzpyrene, a consistent rate of elimination of the hvdrocarbon from the sit'e
of injection, but not to the point of extinction within S5 davs and 10-10 davs
respectively. Extrapolation of the tricaprvlin graph would in&ate total etim"l-
nation in the region of 26 weeks. As W out of 26 mice had tumours bv the 20th
week, it seems reasonable to, suppose, that some benzpyrene was present in these
mice throughout the latent period of careinogenesis. This would correspond
closely with our own experience. In the graph illustrating the course of events
following injection of benzpyrene dissolved in tricaprylin plus 3 per cent choles-
te,rol, Dickens and Weil-Malherbe (1946b) show a considerable variation in the
persistence of benzpyrene in different mice. Thus their final observation on the
78th dav showed no benzpyrene, but in the mouse observed on the 71st dav
about one-twelfth of the iiiftial a'mount of 30A) .Lor. benzpyrene was present. ai.d
some benzpyrene was demonstrated in all the other mice examined during the
course of their experiment up to that date. As no t-umours were recorded before
about the 19th week of their experiment, there is no positive evidence about the
persistence or absence of benzpyrene at the site of injeetion in their tumour-
bearing mice. Ou-r own repetition of their experiment. usinor tricapr.ylin as
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mice, and must therefore have been present throughout the latent period of
carcinogenesis.
While it seems certain that partition ofbenzpyrene between the solvent used
-is vehicle and the body fluids must be largely responsible for the rate ofelimina-
tion of benzpyrene, the local tissue reaction to different solvents may also help
to determine the local response. The further factor of local metabolism of benz-
pyrene iiiay be concerned in the niechanism of carcinogenesis, but the evidence
for the presence of metabolites at the site ofinjection ofbenzpyrene is less sectire
than the evidence for the persistence of the parent hydrocarbon.
The crucial question is the nature and duration of the contact between tlie,
carcinogen and the susceptible cell necessary to ensure carcinogenesis. Unfor-
tunately we have no means of determining the actual latent period between
exposure of a susceptible cell to a carcinogen and its conversion to malignancy,
but the cliiiical latent period from the first exposure to the carcinogen until a
palpable tuniour is recognizable must exceed the actual latent period by aii
uiikiiowi-i aniotint. Moreover, we cannot estimate the proportion of susceptible
cells at a given site ofiiijection actually in contact with the injected carcinogen.
The oiily practical way to ensure a statistically significant yield of tumours is
to expose an excess of cells to an excess of carcinogen for an excessive time.
Uiider such conditions the injected carcinogen forms a depot from which it is
gradually absorbed. There is some evidence (Peacock and Beck, 1938) that
sarcon-ia is most likely to arise, not at the point of maximum concentration of
thecarcinogen, but at somepointalong the route ofitsabsorption, whereoptimum
con(litions occur. The cells in the path of absorption may thus be analogous
to the epithelial cells of the skin exposed to repeated painting with a carcinogeli,
where the iiicidence of tumours varies directly as the length of exposure up to a
maxinial response.
The evidence suggests that carcinogenesis depends oii many factors, only a
few of wliich are under our control, but that, within the latent period for mice
of 3 to 6 months, the chance of inducing a tumour varie's directly as tlie,
persistence ofbenzpyrene at the site ofinjection.
After our experiments were completed, Strait, Hrenoff and de Ome (1948)
published the results ofexperinients on the influence of solvents on the effective-
iiess of carcinogenic agents. They established that for benzpyrene the partition
coefficient between human sera and various lipoid solvents was directly related
to the carcinogenic response of mice injected with benzpyrene dissolved in those
solvents. Solvents that readily parted with benzpyrene in vitro gave fewer
ttimours when used as vehicles for injection of benzpyrene in mice. Their con-
clusions support the conception that there is a significant relationship between
the retention at the site ofinjection ofbenzpyrene and the ultimate carcinogenic
response.
Whatever may be the essential mechanism of conversion of a normal cell to
a malignant one, it seems certain that some local consumption of energy by some
part of the cell must be involved in the transformation. It may well be that the
liberation of energy at the optimum time in the life-cycle of a stisceptible cell is
the essential carcinogenic stimulus, and this may be provided by the metabolism
of a carcinogen. In this event neither theparenthydrocarbon nor its metabolites,
but the transition from one to the other, may provide the essential carcinogenic
stimulus. The possible mechanism of such a stimulus was recently discussed bySOLVENTS AND RESPONSE TO CARCINOGENIC HYDROCARBONS 305
one of us (Anderson, 1947b). We had hoped to obtain from the present series
ofexperimentsenough'local metabolite ofbenzpyrene to test itspossible carcino-
genicity by injection into other mice; but the amounts obtained were barely
enough forspectrographic analysis. Until a method ofidentifying and synthesis-
ing the metabolites ofbenzpyrene isdevised, it seemsunlikelythatenoughmaterial
will becQme available for this crucial test. In the absence of such evidence it
appears that thepresence-ofthe parenthydrocarbonthrough-out the latentperiod
ofcareinogenesis is necessary for ahighyield oflocal sarcoma unde'r the conditions
of our experiment.
SIUMMARY.
1. The evidence that solvents profoundly modify the local action of carcino-
genic hydrocarbons is briefly reviewed.
2. Benzpyrene dissolved in tricaprylin is shown to remain at the site of
injection in progressively diminishing amounts throughout the latent period of
sarcoma induction in stock mice.
3. Towards the end of the latent period evidence of the presence' of a meta-
bolite is found at or near the site ofinjection.
4. No evidence is yet available to show whether benzpyrene acts as such or
through its metabolites to induce sarcoma.
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